DOCSLIB.ORG

Amphetamine Activates Rho Gtpase Signaling to Mediate Dopamine Transporter Internalization and Acute Behavioral Effects of Amphetamine

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Amphetamine Activates Rho Gtpase Signaling to Mediate Dopamine Transporter Internalization and Acute Behavioral Effects of Amphetamine Amphetamine activates Rho GTPase signaling to mediate dopamine transporter internalization and acute behavioral effects of amphetamine David S. Wheelera,1,2, Suzanne M. Underhillb,2,3, Donna B. Stolzc, Geoffrey H. Murdochd, Edda Thielse, Guillermo Romeroa, and Susan G. Amarab,3 aDepartment of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA 15213; bLaboratory of Molecular and Cellular Neurobiology, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892; cCenter for Biologic Imaging, University of Pittsburgh, Pittsburgh, PA 15261; dDepartment of Pathology, Division of Neuropathology, University of Pittsburgh, Pittsburgh, PA 15213; and eDepartment of Neurobiology, Center for the Neural Basis of Cognition, Center for Neuroscience, University of Pittsburgh, Pittsburgh, PA 15260 Contributed by Susan G. Amara, October 2, 2015 (sent for review September 3, 2015; reviewed by Aurelio Galli, Harald H. Sitte, and Roxanne A. Vaughan) Acute amphetamine (AMPH) exposure elevates extracellular do- the same machinery would be involved in AMPH-mediated in- pamine through a variety of mechanisms that include inhibition of ternalization. A secondary pathway of dynamin-mediated inter- dopamine reuptake, depletion of vesicular stores, and facilitation nalization of membrane-localized proteins involves small GTPases of dopamine efflux across the plasma membrane. Recent work has of the Rho family. Rho proteins are composed of three subfam- shown that the DAT substrate AMPH, unlike cocaine and other ilies (Rho, Rac, and CDC42), each of which play a major role in nontransported blockers, can also stimulate endocytosis of the actin cytoskeletal reorganization and vesicular trafficking (10). To plasma membrane dopamine transporter (DAT). Here, we show further characterize the dynamin-dependent mechanism of DAT that when AMPH enters the cytoplasm it rapidly stimulates DAT internalization in response to AMPH, we examined if it was me- internalization through a dynamin-dependent, clathrin-indepen- diated by clathrin or whether it was a Rho-dependent process. dent process. This effect, which can be observed in transfected We also sought to resolve which signaling pathways activated cells, cultured dopamine neurons, and midbrain slices, is mediated by AMPH trigger internalization, whether these effects reflect a by activation of the small GTPase RhoA. Inhibition of RhoA activity direct intracellular action of AMPH, and whether they depend with C3 exotoxin or a dominant-negative RhoA blocks AMPH- on the elevation of extracellular dopamine. induced DAT internalization. These actions depend on AMPH entry Here, we demonstrate that AMPH [(+)-α-methyl phenylethyl- into the cell and are blocked by the DAT inhibitor cocaine. AMPH amine] acts within the cytoplasm to stimulate Rho family GTPases also stimulates cAMP accumulation and PKA-dependent inactiva- and trigger DAT internalization through a Rho- and dynamin- tion of RhoA, thus providing a mechanism whereby PKA- and dependent pathway that does not involve clathrin. We also show RhoA-dependent signaling pathways can interact to regulate the timing and robustness of AMPH’s effects on DAT internalization. Consistent with this model, the activation of D1/D5 receptors that Significance couple to PKA in dopamine neurons antagonizes RhoA activation, DAT internalization, and hyperlocomotion observed in mice after The dopamine transporter (DAT), a major target for psychosti- AMPH treatment. These observations support the existence of an mulant drugs, including cocaine and amphetamines, clears ex- unanticipated intracellular target that mediates the effects of AMPH tracellular dopamine and restricts the temporal and spatial on RhoA and cAMP signaling and suggest new pathways to target extent of neurotransmitter signaling. This study examines the to disrupt AMPH action. mechanism through which amphetamines trigger internalization of DAT and demonstrates that amphetamine activates the small dopamine transporter | amphetamine | Rho GTPase | protein kinase A | GTPases, Rho and Rac. Rho activation triggers endocytosis of endocytosis DAT by a dynamin-dependent, clathrin-independent pathway. Intriguingly, amphetamine must enter the cell to have these effects, and it also increases cAMP, which in turn inactivates Rho oth cocaine and amphetamine (AMPH) are psychostimulants and limits carrier internalization. Consistent with these obser- that induce euphoria and hyperactivity by increasing extra- B vations, the activation of receptors that couple to protein kinase A cellular dopamine. Despite the apparent commonalities in the in dopamine neurons also antagonizes the behavioral effects effects and mechanism of action of the two drugs, amphetamine of amphetamine in mice, suggesting new pathways to target exposure has behavioral, neuroadaptive, and neurotoxic conse- to disrupt amphetamine action. quences not associated with cocaine use (1–5). These dissimi- larities likely stem from several differences in the mechanism of Author contributions: D.S.W., S.M.U., G.H.M., E.T., G.R., and S.G.A. designed research; D.S.W., action of the two drugs. Amphetamines, unlike cocaine and S.M.U., D.B.S., G.H.M., and E.T. performed research; G.R. and S.G.A. contributed new other nontransported inhibitors of the dopamine transporter reagents/analytic tools; D.S.W., S.M.U., G.H.M., E.T., G.R., and S.G.A. analyzed data; and (DAT), are transporter substrates that compete with dopamine D.S.W., S.M.U., G.H.M., G.R., and S.G.A. wrote the paper. for transport, enter dopamine neurons, enhance efflux of dopa- Reviewers: A.G., Vanderbilt University; H.H.S., Medical University Vienna, Center for Physiology and Pharmacology; and R.A.V., University of North Dakota School of Medicine & mine, and also stimulate internalization of the DAT from the cell Health Sciences. surface (6, 7). To better understand how amphetamines mediate The authors declare no conflict of interest. their effects within the cell, we undertook a series of studies to See Commentary on page 15538. establish the cellular pathways and signaling mechanisms that 1Present address: Department of Medicine, Einstein Medical Center Philadelphia, Philadelphia, underlie the endocytosis of the DAT triggered by amphetamines. PA 19141. AMPH-mediated DAT internalization has been shown to be 2D.S.W. and S.M.U. contributed equally to this work. dynamin-dependent (6). Dynamin-dependence is a key feature 3 To whom correspondence may be addressed. Email: [email protected] or smunderhill@ of clathrin-mediated endocytosis, and, indeed, previous reports yahoo.com. of clathrin-dependent constitutive cycling (8) and PKC-mediated This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. internalization (9) of DAT make it reasonable to consider that 1073/pnas.1511670112/-/DCSupplemental. E7138–E7147 | PNAS | Published online November 9, 2015 www.pnas.org/cgi/doi/10.1073/pnas.1511670112 Downloaded by guest on October 1, 2021 that cytoplasmic AMPH stimulates a secondary pathway of cAMP total internal reflection fluorescence (TIRF) microscopy dem- PNAS PLUS production, which leads to Rho inactivation by PKA-dependent onstrate that less than 0.5% of internalizing DAT colocalizes phosphorylation. This transient period of Rho activation corre- with clathrin (Movie S1). In contrast, parallel experiments lates with ongoing DAT internalization, and this temporal window monitoring transferrin accumulation confirm previous studies of activation can be shortened by stimulating cell-surface Gs- that over 80% of internalizing transferrin colocalizes with clathrin coupled receptors to raise cAMP and increase the rate of Rho (Fig. 1B). Thus, AMPH-stimulated DAT internalization in inactivation. We also show in vivo that preemptive D1/D5 re- SK-N-SH cells is dynamin-dependent, but clathrin-independent. ceptor stimulation to activate PKA can reduce AMPH-evoked Dynamin-dependent, clathrin-independent internalization is gen- hyperlocomotion without altering the increase in locomotion in- erally divided into two categories depending on whether Rho ac- duced by cocaine. Because these signaling events occur in trans- tivation is required (11). Coexpression of the DAT with a plasmid fected cell lines as well as in neurons, the results indicate that, once encoding GFP-tagged C3 exotoxin, a clostridial enzyme that ADP SEE COMMENTARY AMPH enters the cell, it activates Rho, Rac, and PKA signaling ribosylates and inactivates Rho family GTPases, prevents AMPH- independently of any actions to elevate intracellular dopamine. The induced clustering and internalization of DAT in SK-N-SH cells direct activation of cytoplasmic signaling cascades by AMPH within (Fig. 1 C–E and Movie S2). Using TIRF microscopy we observed the cell can contribute to the behavioral effects of acute amphet- that expression of C3 for 18–24 h in SK-N-SH cells reduces the amine exposure and may explain some of the unique neurobiolog- number of focal adhesions, consistent with Rho inhibition. The ical consequences associated with amphetamine use and abuse. continuing spontaneous movement of the C3(+) cells and their ability to transport dopamine (Fig. 1F) indicate that the cells are Results still viable. The presence of the Rho inhibitor prevented the AMPH-Induced DAT Internalization Is Clathrin-Independent. Previous increase in DAT endocytosis observed with AMPH, supporting a studies have indicated that the endocytosis of DAT activated by role for Rho-GTPases in DAT internalization. AMPH
Load more

Recommended publications
  • Is TAAR1 a Potential Therapeutic Target for Immune Dysregulation In
    Graduate Physical and Life Sciences PhD Pharmacology Abstract ID# 1081 Is TAAR1 a Potential Therapeutic Target for Immune Dysregulation in Drug Abuse? Fleischer, Lisa M; Tamashunas, Nina and Miller, Gregory M Addiction Sciences Laboratory, Northeastern University, Boston MA 02115 Abstract Discovered in 2001, Trace Amine Associated Receptor 1 (TAAR1) is a direct target of Data and Results amphetamine, methamphetamine and MDMA. It is expressed in the brain reward circuity and modulates dopamine transporter function and dopamine neuron firing rates. Newly-developed compounds that specifically target TAAR1 have recently been investigated in animal models In addition to brain, TAAR1 is expressed in immune cells METH promotes PKA and PKC Phosphorylation through TAAR1 as candidate therapeutics for methamphetamine, cocaine and alcohol abuse. These studies • We treated HEK/TAAR1 cells and HEK293 involving classic behavioral measures of drug response, as well as drug self-administration, Rhesus and Human cells with vehicle or METH, with and without strongly implicate TAAR1 as a potential therapeutic target for the treatment of addiction. In activators and inhibitors of PKA and PKC. addition to its central actions, we demonstrated that TAAR1 is upregulated in peripheral blood Cells Lines mononuclear cells (PBMC) and B cells following immune activation, and that subsequent • We performed Western blotting experiments to activation of TAAR1 by methamphetamine stimulates cAMP, similar to the function of measure levels of phospho-PKA and phospho- adenosine A2 receptors which are also present in immune cells and play a critical role in the PKC. immune response. Here, we are investigating the relationship between TAAR1 and the • We found that specific activators of PKA and adenosine A2 receptor at the level of cellular signaling and receptor dimerization.
    [Show full text]
  • Discovery of Novel Imidazolines and Imidazoles As Selective TAAR1
    Discovery of Novel Imidazolines and Imidazoles as Selective TAAR1 Partial Agonists for the Treatment of Psychiatric Disorders Giuseppe Cecere, pRED, Discovery Chemistry F. Hoffmann-La Roche AG, Basel, Switzerland Biological Rationale Trace amines are known for four decades Trace Amines - phenylethylamine p- tyramine p- octopamine tryptamine (PEA) Biogenic Amines dopamine norepinephrine serotonin ( DA) (NE) (5-HT) • Structurally related to classical biogenic amine neurotransmitters (DA, NE, 5-HT) • Co-localised & released with biogenic amines in same cells and vesicles • Low concentrations in CNS, rapidly catabolized by monoamine oxidase (MAO) • Dysregulation linked to psychiatric disorders such as schizophrenia & 2 depression Trace Amines Metabolism 3 Biological Rationale Trace Amine-Associated Receptors (TAARs) p-Tyramine extracellular TAAR1 Discrete family of GPCR’s Subtypes TAAR1-TAAR9 known intracellular Gs Structural similarity with the rhodopsin and adrenergic receptor superfamily adenylate Activation of the TAAR1 cyclase receptor leads to cAMP elevation of intracellular cAMP levels • First discovered in 2001 (Borowsky & Bunzow); characterised and classified at Roche in 2004 • Trace amines are endogenous ligands of TAAR1 • TAAR1 is expressed throughout the limbic and monoaminergic system in the brain Borowsky, B. et al., PNAS 2001, 98, 8966; Bunzow, J. R. et al., Mol. Pharmacol. 2001, 60, 1181. Lindemann L, Hoener MC, Trends Pharmacol Sci 2005, 26, 274. 4 Biological Rationale Electrical activity of dopaminergic neurons + p-tyramine
    [Show full text]
  • Characterization of Dopaminergic System in the Striatum of Young Adult Park2-/- Knockout Rats
    www.nature.com/scientificreports OPEN Characterization of Dopaminergic System in the Striatum of Young Adult Park2−/− Knockout Rats Received: 27 June 2016 Jickssa M. Gemechu1,2, Akhil Sharma1, Dongyue Yu1,3, Yuran Xie1,4, Olivia M. Merkel 1,5 & Accepted: 20 November 2017 Anna Moszczynska 1 Published: xx xx xxxx Mutations in parkin gene (Park2) are linked to early-onset autosomal recessive Parkinson’s disease (PD) and young-onset sporadic PD. Park2 knockout (PKO) rodents; however, do not display neurodegeneration of the nigrostriatal pathway, suggesting age-dependent compensatory changes. Our goal was to examine dopaminergic (DAergic) system in the striatum of 2 month-old PKO rats in order to characterize compensatory mechanisms that may have occurred within the system. The striata form wild type (WT) and PKO Long Evans male rats were assessed for the levels of DAergic markers, for monoamine oxidase (MAO) A and B activities and levels, and for the levels of their respective preferred substrates, serotonin (5-HT) and ß-phenylethylamine (ß-PEA). The PKO rats displayed lower activities of MAOs and higher levels of ß-PEA in the striatum than their WT counterparts. Decreased levels of ß-PEA receptor, trace amine-associated receptor 1 (TAAR-1), and postsynaptic DA D2 (D2L) receptor accompanied these alterations. Drug-naive PKO rats displayed normal locomotor activity; however, they displayed decreased locomotor response to a low dose of psychostimulant methamphetamine, suggesting altered DAergic neurotransmission in the striatum when challenged with an indirect agonist. Altogether, our fndings suggest that 2 month-old PKO male rats have altered DAergic and trace aminergic signaling.
    [Show full text]
  • Identification of a Subset of Trace Amine-Associated Receptors and Ligands As Potential Modulators of Insulin Secretion
    Journal Pre-proofs Identification of a subset of trace amine-associated receptors and ligands as po- tential modulators of insulin secretion Michael J. Cripps, Marta Bagnati, Tania A. Jones, Babatunji W. Ogunkolade, Sophie R. Sayers, Paul W. Caton, Katie Hanna, Merell Billacura, Kathryn Fair, Carl Nelson, Robert Lowe, Graham A. Hitman, Mark D. Berry, Mark D. Turner PII: S0006-2952(19)30384-3 DOI: https://doi.org/10.1016/j.bcp.2019.113685 Reference: BCP 113685 To appear in: Biochemical Pharmacology Received Date: 22 August 2019 Accepted Date: 24 October 2019 Please cite this article as: M.J. Cripps, M. Bagnati, T.A. Jones, B.W. Ogunkolade, S.R. Sayers, P.W. Caton, K. Hanna, M. Billacura, K. Fair, C. Nelson, R. Lowe, G.A. Hitman, M.D. Berry, M.D. Turner, Identification of a subset of trace amine-associated receptors and ligands as potential modulators of insulin secretion, Biochemical Pharmacology (2019), doi: https://doi.org/10.1016/j.bcp.2019.113685 This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2019 Elsevier Inc. All rights reserved.
    [Show full text]
  • Involvement of the Sigma-1 Receptor in Methamphetamine-Mediated Changes to Astrocyte Structure and Function" (2020)
    University of Kentucky UKnowledge Theses and Dissertations--Medical Sciences Medical Sciences 2020 Involvement of the Sigma-1 Receptor in Methamphetamine- Mediated Changes to Astrocyte Structure and Function Richik Neogi University of Kentucky, [email protected] Author ORCID Identifier: https://orcid.org/0000-0002-8716-8812 Digital Object Identifier: https://doi.org/10.13023/etd.2020.363 Right click to open a feedback form in a new tab to let us know how this document benefits ou.y Recommended Citation Neogi, Richik, "Involvement of the Sigma-1 Receptor in Methamphetamine-Mediated Changes to Astrocyte Structure and Function" (2020). Theses and Dissertations--Medical Sciences. 12. https://uknowledge.uky.edu/medsci_etds/12 This Master's Thesis is brought to you for free and open access by the Medical Sciences at UKnowledge. It has been accepted for inclusion in Theses and Dissertations--Medical Sciences by an authorized administrator of UKnowledge. For more information, please contact [email protected]. STUDENT AGREEMENT: I represent that my thesis or dissertation and abstract are my original work. Proper attribution has been given to all outside sources. I understand that I am solely responsible for obtaining any needed copyright permissions. I have obtained needed written permission statement(s) from the owner(s) of each third-party copyrighted matter to be included in my work, allowing electronic distribution (if such use is not permitted by the fair use doctrine) which will be submitted to UKnowledge as Additional File. I hereby grant to The University of Kentucky and its agents the irrevocable, non-exclusive, and royalty-free license to archive and make accessible my work in whole or in part in all forms of media, now or hereafter known.
    [Show full text]
  • Receptor Interaction Profiles of 4-Alkoxy-Substituted 2,5-Dimethoxyphenethylamines and Related Amphetamines
    ORIGINAL RESEARCH published: 28 November 2019 doi: 10.3389/fphar.2019.01423 Receptor Interaction Profiles of 4-Alkoxy-Substituted 2,5-Dimethoxyphenethylamines and Related Amphetamines Karolina E. Kolaczynska 1, Dino Luethi 1,2, Daniel Trachsel 3, Marius C. Hoener 4 and Matthias E. Liechti 1* 1 Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland, 2 Center for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, Vienna, Austria, 3 ReseaChem GmbH, Burgdorf, Switzerland, 4 Neuroscience Research, pRED, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland Background: 2,4,5-Trimethoxyamphetamine (TMA-2) is a potent psychedelic compound. Structurally related 4-alkyloxy-substituted 2,5-dimethoxyamphetamines and phenethylamine congeners (2C-O derivatives) have been described but their pharmacology Edited by: is mostly undefined. Therefore, we examined receptor binding and activation profiles of M. Foster Olive, these derivatives at monoamine receptors and transporters. Arizona State University, United States Methods: Receptor binding affinities were determined at the serotonergic 5-HT1A, 5-HT2A, Reviewed by: Luc Maroteaux, and 5-HT2C receptors, trace amine-associated receptor 1 (TAAR1), adrenergic α1 and INSERM U839 Institut du Fer à α2 receptors, dopaminergic D2 receptor, and at monoamine transporters, using target- Moulin, France Simon D. Brandt, transfected cells. Additionally, activation of 5-HT2A and 5-HT2B receptors and TAAR1 was Liverpool John Moores University, determined. Furthermore, we assessed monoamine transporter inhibition. United Kingdom Results: Both the phenethylamine and amphetamine derivatives (Ki = 8–1700 nM and *Correspondence: Matthias E. Liechti 61–4400 nM, respectively) bound with moderate to high affinities to the 5-HT2A receptor [email protected] with preference over the 5-HT1A and 5-HT2C receptors (5-HT2A/5-HT1A = 1.4–333 and Specialty section: 5-HT2A/5-HT2C = 2.1–14, respectively).
    [Show full text]
  • The Involvement of Trace Amine-Associated Receptor 1 and Thyroid Hormone Transporters in Non-Classical Pathways of the Thyroid Gland Auto-Regulation
    The Involvement of Trace Amine-Associated Receptor 1 and Thyroid Hormone Transporters in Non-Classical Pathways of the Thyroid Gland Auto-Regulation by Maria Qatato a Thesis submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Cell Biology Approved Dissertation Committee Prof. Dr. Klaudia Brix Jacobs University Bremen Prof. Sebastian Springer, DPhil Jacobs University Bremen Dr. Georg Homuth Ernst-Moritz-Arndt-Universität Greifswald Date of Defence: 16 January 2018 Department of Life Sciences and Chemistry Statutory Declaration Family Name, Given/First Name Qatato, Maria Matriculation number 20330110 What kind of thesis are you submitting: PhD Thesis English: Declaration of Authorship I hereby declare that the thesis submitted was created and written solely by myself without any external support. Any sources, direct or indirect, are marked as such. I am aware of the fact that the contents of the thesis in digital form may be revised with regard to usage of unauthorized aid as well as whether the whole or parts of it may be identified as plagiarism. I do agree my work to be entered into a database for it to be compared with existing sources, where it will remain in order to enable further comparisons with future theses. This does not grant any rights of reproduction and usage, however. This document was neither presented to any other examination board nor has it been published. German: Erklärung der Autorenschaft (Urheberschaft) Ich erkläre hiermit, dass die vorliegende Arbeit ohne fremde Hilfe ausschließlich von mir erstellt und geschrieben worden ist. Jedwede verwendeten Quellen, direkter oder indirekter Art, sind als solche kenntlich gemacht worden.
    [Show full text]
  • TAAR1 Modulates Cortical Glutamate NMDA Receptor Function
    Neuropsychopharmacology (2015) 40, 2217–2227 © 2015 American College of Neuropsychopharmacology. All rights reserved 0893-133X/15 www.neuropsychopharmacology.org TAAR1 Modulates Cortical Glutamate NMDA Receptor Function Stefano Espinoza1, Gabriele Lignani1, Lucia Caffino2, Silvia Maggi1, Ilya Sukhanov1,3, Damiana Leo1, Liudmila Mus1, Marco Emanuele1, Giuseppe Ronzitti1, Anja Harmeier4, Lucian Medrihan1, 1,5 1 4 1 1 Tatyana D Sotnikova , Evelina Chieregatti , Marius C Hoener , Fabio Benfenati , Valter Tucci , 2 *,1,5,6 Fabio Fumagalli and Raul R Gainetdinov 1Department of Neuroscience and Brain Technologies, Istituto Italiano di Tecnologia, Genova, Italy; 2Dipartimento di Scienze Farmacologiche e 3 Biomolecolari, Università degli Studi di Milano, Milan, Italy; Department of Pharmacology, St Petersburg State Medical University, Petersburg, 4 Russia; Neuroscience, Ophthalmology and Rare Diseases Discovery and Translational Area, pRED, Roche Innovation Center Basel, F. Hoffmann- 5 La Roche Ltd, Basel, Switzerland; Institute of Translational Biomedicine, Faculty of Biology, St Petersburg State University, St Petersburg, Russia; 6 Skolkovo Institute of Science and Technology (Skoltech) Skolkovo, Moscow region, Russia Trace Amine-Associated Receptor 1 (TAAR1) is a G protein-coupled receptor expressed in the mammalian brain and known to influence subcortical monoaminergic transmission. Monoamines, such as dopamine, also play an important role within the prefrontal cortex (PFC) circuitry, which is critically involved in high-o5rder cognitive processes. TAAR1-selective ligands have shown potential antipsychotic, antidepressant, and pro-cognitive effects in experimental animal models; however, it remains unclear whether TAAR1 can affect PFC- related processes and functions. In this study, we document a distinct pattern of expression of TAAR1 in the PFC, as well as altered subunit composition and deficient functionality of the glutamate N-methyl-D-aspartate (NMDA) receptors in the pyramidal neurons of layer V of PFC in mice lacking TAAR1.
    [Show full text]
  • SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D2 Receptor Mechanism of Action S
    Supplemental material to this article can be found at: http://jpet.aspetjournals.org/content/suppl/2019/08/01/jpet.119.260281.DC1 1521-0103/371/1/1–14$35.00 https://doi.org/10.1124/jpet.119.260281 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS J Pharmacol Exp Ther 371:1–14, October 2019 Copyright ª 2019 by The Author(s) This is an open access article distributed under the CC BY-NC Attribution 4.0 International license. SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D2 Receptor Mechanism of Action s Nina Dedic,1 Philip G. Jones,1 Seth C. Hopkins, Robert Lew, Liming Shao, John E. Campbell, Kerry L. Spear, Thomas H. Large, Una C. Campbell, Taleen Hanania, Emer Leahy, and Kenneth S. Koblan Sunovion Pharmaceuticals, Marlborough, Massachusetts (N.D., P.G.J., S.C.H., R.L., L.S., J.E.C., K.L.S., T.H.L., U.C.C., K.S.K.); and PsychoGenics, Paramus, New Jersey (T.H., E.L.) Received May 24, 2019; accepted July 10, 2019 Downloaded from ABSTRACT For the past 50 years, the clinical efficacy of antipsychotic amine-associated receptor 1 and 5-HT1A receptors is integral to medications has relied on blockade of dopamine D2 receptors. its efficacy. Based on the preclinical data and its unique Drug development of non-D2 compounds, seeking to avoid mechanism of action, SEP-856 is a promising new agent for the limiting side effects of dopamine receptor blockade, has the treatment of schizophrenia and represents a new pharma- jpet.aspetjournals.org failed to date to yield new medicines for patients.
    [Show full text]
  • TAAR5) Knockout Mice
    International Journal of Molecular Sciences Article Minor Changes in Erythrocyte Osmotic Fragility in Trace Amine-Associated Receptor 5 (TAAR5) Knockout Mice Ilya S. Zhukov 1,2 , Larisa G. Kubarskaya 2,3, Inessa V. Karpova 2 , Anastasia N. Vaganova 1, Marina N. Karpenko 2 and Raul R. Gainetdinov 1,4,* 1 Institute of Translational Biomedicine, Saint Petersburg State University, 199034 Saint Petersburg, Russia; [email protected] (I.S.Z.); [email protected] (A.N.V.) 2 Institute of Experimental Medicine, 197376 Saint Petersburg, Russia; [email protected] (L.G.K.); [email protected] (I.V.K.); [email protected] (M.N.K.) 3 Institute of Toxicology of Federal Medical-Biological Agency, 192019 Saint Petersburg, Russia 4 Saint Petersburg State University Hospital, Saint Petersburg State University, 199034 Saint Petersburg, Russia * Correspondence: [email protected] Abstract: Trace amine-associated receptors (TAARs) are a group of G protein-coupled receptors that are expressed in the olfactory epithelium, central nervous system, and periphery. TAAR family generally consists of nine types of receptors (TAAR1-9), which can detect biogenic amines. During the last 5 years, the TAAR5 receptor became one of the most intriguing receptors in this subfamily. Recent studies revealed that TAAR5 is involved not only in sensing socially relevant odors but also in the regulation of dopamine and serotonin transmission, emotional regulation, and adult neurogenesis by providing significant input from the olfactory system to the limbic brain areas. Such results indicate that future antagonistic TAAR5-based therapies may have high pharmacological Citation: Zhukov, I.S.; Kubarskaya, potential in the field of neuropsychiatric disorders.
    [Show full text]
  • Trace Amine-Associated Receptor 1 Trafficking to Cilia of Thyroid Epithelial Cells
    cells Article Trace Amine-Associated Receptor 1 Trafficking to Cilia of Thyroid Epithelial Cells Maria Qatato, Vaishnavi Venugopalan † , Alaa Al-Hashimi †, Maren Rehders †, Aaron D. Valentine , Zeynep Hein, Uillred Dallto, Sebastian Springer and Klaudia Brix * Department of Life Sciences and Chemistry, Focus Area HEALTH, Jacobs University Bremen, Campus Ring 1, D-28759 Bremen, Germany; [email protected] (M.Q.); [email protected] (V.V.); [email protected] (A.A.-H.); [email protected] (M.R.); [email protected] (A.D.V.); [email protected] (Z.H.); [email protected] (U.D.); [email protected] (S.S.) * Correspondence: [email protected]; Tel.: +49-421-200-3246 † These authors contributed equally to this study. Abstract: Trace amine-associated receptor 1 (rodent Taar1/human TAAR1) is a G protein-coupled receptor that is mainly recognized for its functions in neuromodulation. Previous in vitro studies suggested that Taar1 may signal from intracellular compartments. However, we have shown Taar1 to localize apically and on ciliary extensions in rodent thyrocytes, suggesting that at least in the thyroid, Taar1 may signal from the cilia at the apical plasma membrane domain of thyrocytes in situ, where it is exposed to the content of the follicle lumen containing putative Taar1 ligands. This study was designed to explore mouse Taar1 (mTaar1) trafficking, heterologously expressed in human and rat thyroid cell lines in order to establish an in vitro system in which Taar1 signaling from the cell Citation: Qatato, M.; Venugopalan, surface can be studied in future.
    [Show full text]
  • A Second Class of Chemosensory Receptors in the Olfactory Epithelium
    Vol 442|10 August 2006|doi:10.1038/nature05066 ARTICLES A second class of chemosensory receptors in the olfactory epithelium Stephen D. Liberles1 & Linda B. Buck1 The mammalian olfactory system detects chemicals sensed as odours as well as social cues that stimulate innate responses. Odorants are detected in the nasal olfactory epithelium by the odorant receptor family, whose ,1,000 members allow the discrimination of a myriad of odorants. Here we report the discovery of a second family of receptors in the mouse olfactory epithelium. Genes encoding these receptors, called ‘trace amine-associated receptors’ (TAARs), are present in human, mouse and fish. Like odorant receptors, individual mouse TAARs are expressed in unique subsets of neurons dispersed in the epithelium. Notably, at least three mouse TAARs recognize volatile amines found in urine: one detects a compound linked to stress, whereas the other two detect compounds enriched in male versus female urine—one of which is reportedly a pheromone. The evolutionary conservation of the TAAR family suggests a chemosensory function distinct from odorant receptors. Ligands identified for TAARs thus far suggest a function associated with the detection of social cues. The first step in odour perception is the detection of odorants by G which we then used in real-time quantitative PCR (qPCR) reactions protein-coupled odorant receptors on olfactory sensory neurons with primers matching GPCRs not previously implicated in odour, (OSNs) in the nasal olfactory epithelium1–3. In response to odorants, pheromone or taste detection19. cDNAs encoding individual GPCRs OSNs transmit signals to the brain, thereby generating odour were quantified using standard curves obtained from qPCR reactions perceptions2,4.
    [Show full text]